Product image of Levetiracetam 1a Pharma (Levetiracetam) supplied by GNH India

Levetiracetam 1a Pharma

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam 1a Pharma (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam 1a Pharma, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial onset seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients with epilepsy.

GNH India supplies Levetiracetam 1a Pharma as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide from its EU‑origin manufacturing facilities and ensuring quality compliance with EU pharmacopeial standards.

Manufacturer / TM Owner

1a Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levetiracetam is an anticonvulsant used to manage various seizure types in epilepsy.
  • Partial onset seizures: reduces seizure frequency and helps achieve seizure control.
  • Generalized tonic‑clonic seizures: decreases occurrence of convulsive episodes.
  • Myoclonic seizures: lessens rapid muscle jerks associated with epilepsy.

How It Works

  • Levetiracetam binds selectively to the synaptic vesicle protein SV2A, a regulator of neurotransmitter release. This interaction modulates synaptic transmission, decreasing excessive neuronal firing and reducing neuronal excitability, which contributes to its antiepileptic effect across multiple seizure types.

Side Effects

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Dizziness
  • Fatigue
  • Somnolence
  • Headache
  • Irritability
  • Nausea

Serious or Rare Side Effects

  • Severe skin reactions such as Stevens‑Johnson syndrome
  • Suicidal thoughts or behavior
  • Major depressive episodes
  • Blood dyscrasias (e.g., neutropenia, thrombocytopenia)
  • Anaphylactic or severe hypersensitivity reactions
  • Multi‑organ involvement including hepatic or renal impairment

Precautions & Warnings

When prescribing levetiracetam, clinicians should consider several safety aspects.

  • Renal impairment: adjust dose based on renal function.
  • Mood changes: monitor for depression, anxiety, or suicidal ideation.
  • Discontinuation: avoid abrupt cessation to prevent seizure exacerbation.
  • Elderly patients: start at lower doses and titrate cautiously.
  • Pregnancy: safety category unknown; weigh benefits against potential risks.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Carbamazepine: may lower levetiracetam plasma concentrations.
  • Strong enzyme inducers (e.g., phenytoin, phenobarbital): can reduce levetiracetam levels.
  • Concomitant use with other antiepileptics that significantly alter renal clearance.

Moderate Interactions (Monitor Closely)

  • CNS depressants (e.g., benzodiazepines, alcohol): may increase sedation.
  • Antidepressants or mood stabilizers: monitor for additive mood effects.
  • Antacids: may affect absorption; observe therapeutic response.

Frequently Asked Questions

Levetiracetam 1a Pharma is prescribed for the management of epilepsy, specifically for partial onset seizures, generalized tonic‑clonic seizures, and myoclonic seizures. It helps reduce the frequency and severity of these seizure types in patients diagnosed with epilepsy.

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and reduces excessive excitability, thereby preventing the rapid, uncontrolled electrical activity that leads to seizures.

The appropriate dose of Levetiracetam 1a Pharma is determined by the prescribing healthcare professional based on the patient’s age, weight, renal function, and seizure type. Dosage adjustments are individualized and should follow the prescriber’s instructions.

Levetiracetam’s safety in pregnancy and lactation is not fully established. It is classified as having an unknown pregnancy category, so clinicians must weigh potential benefits against possible risks and discuss options with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam is distinguished by its unique SV2A binding mechanism, which offers a favorable side‑effect profile compared with many older antiepileptics that act on sodium channels or GABA receptors. It is often chosen for patients who need a well‑tolerated option with minimal drug‑enzyme interactions.

Levetiracetam 1a Pharma should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain product stability.

Levetiracetam 1a Pharma is taken orally, usually as a tablet. It can be swallowed whole with water, and may be taken with or without food, according to the prescriber’s guidance.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, significant mood changes including depression or suicidal thoughts, and rare blood disorders like neutropenia. Patients should report any rash, mood alteration, or unusual symptoms promptly to their healthcare provider.

Levetiracetam is contraindicated in patients with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for individuals with severe renal impairment unless dose adjustments are made, and it should be avoided in patients with a history of severe psychiatric reactions to the drug.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT